Obesity drugs are rapidly moving from the margins of lifestyle care to the centre of India’s pharmaceutical growth story as rising lifestyle diseases, new blockbuster launches and the looming entry of low-cost generics reshape the market. With global consultants McKinsey ranking obesity therapies alongside AI, electric vehicles and robotics as trillion-dollar opportunities by 2040, India…
Drug maker Abbott Healthcare has asked stockists and distributors to stock up medicines only from authorised and genuine suppliers after the government of Puducherry issued an alert regarding the seizure of spurious versions of drugs under the brand names of major pharmaceutical companies, including Torrent Pharmaceuticals, MSD Pharmaceuticals Pvt Ltd, Sanofi India, Dr Reddy’s Laboratories,…
Bombay HC Quashes Maharashtra FDA, CDSCO Stop-Production Orders Against 2 Pharma Firms We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
SC Questions Effectiveness of UCPMP, Seeks Govt Clarification on Pharma Freebies We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Tamil Nadu Pharma Firms Under ED Lens for Suspected Financial Irregularities We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
UCPMP 2024: Govt Details Stricter Rules to Curb Gifts, Incentives from Pharma to Doctors We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
NPPA Slapped Rs 9,950 Cr Penalty On Pharma Firms, Recovered Only 14.25% We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link